HCPCS code C1814: Retinal tamponade device billing guide

Key takeaways

HCPCS code C1814 reports a silicone oil retinal tamponade device used during vitreoretinal surgery.

C1814 is a Level II C-code, so it belongs on hospital outpatient and ASC claims under OPPS.

The device code never stands alone, and it always sits beside the surgical CPT code on the same claim.

Most denials trace back to the wrong place of service, a missing RT or LT modifier, or a vague operative note.

OPPS packaging decides whether the device is paid separately, and no modifier can override that.

HCPCS code C1814 reports a retinal tamponade device made of silicone oil. It describes a device, not a procedure, and that single distinction shapes almost everything about the claim.

The oil itself is simple. Billing it is where outpatient teams lose money. The code works in two settings only, it never travels alone, and the operative note has to name the agent. Miss any one of those and the claim comes straight back.

Start with what the descriptor says. Neighboring C-codes look almost identical on a claim scrubber, yet they describe completely different devices.

HCPCS code C1814 covers one device and nothing else

C1814 has one official descriptor, and it reads the same across every CMS code file and major coding reference. It classifies a medical device, which is why the code always needs a companion procedure code to make sense on a claim.

CMS assigns and maintains C-codes, not the American Medical Association. According to the Centers for Medicare and Medicaid Services, C-codes report devices, drugs, and biologicals on outpatient facility claims. They cover items that sit outside the standard CPT set.

C1814 lives in the C1760-C2615 block of assorted device and implant C-codes. That block starts at C1760 and runs through vascular, urological, and neurostimulator devices before it ever reaches the eye.

Why surgeons reach for silicone oil instead of gas

Knowing what the device does helps billers catch documentation problems before submission. Silicone oil is a viscous fluid injected into the vitreous cavity during vitreoretinal surgery. It supports detached retinal tissue mechanically, holding the retina in place while healing happens.

Surgeons choose it in a handful of situations:

• Rhegmatogenous retinal detachment repair where gas tamponade has failed or is not suitable
• Complex detachments involving proliferative vitreoretinopathy (PVR)
• Giant retinal tears that need extended intraocular support
• Vitrectomy procedures where prolonged tamponade is required
• Reattachment after trauma or severe posterior segment injury

Gas tamponade agents are absorbed by the body. Silicone oil is not, so a second procedure is usually needed to remove it once the retina is stable. For billing teams, that means two separate surgeries with two separate CPT codes. C1814 reports only the device that went in at the first one.

C1814 only works in two care settings

C-codes are hard-wired to OPPS, and that limits where the code can legitimately appear. The table below shows which claims accept it.

Billing C1814 from a physician-office place of service is the single most common reason this claim denies. In a HOPD or ASC, the device cost is reimbursed through the facility’s Ambulatory Payment Classification (APC) grouping.

That sits apart from the surgeon’s professional fee. Both claims can go out for the same procedure, but only the facility claim carries C1814.

What Medicare pays for C1814 in 2026

Medicare pays C1814 under OPPS through an APC rate rather than a fixed fee. The current figures live in the annual OPPS final rule and the payment files that go with it. Check the CMS hospital outpatient PPS files and Addendum B for the APC assignment that applies this year.

Rates move with APC grouping, cost outlier status, and the geographic wage index. A figure quoted anywhere else is a starting point, not an answer. Our fee schedule reference guides explain how device payment systems are structured more broadly.

Packaging is the default, not the exception

Most device C-codes are packaged under OPPS. Payment for the device folds into the APC rate for the surgical procedure, so the facility receives one payment instead of two. Addendum B tells you which treatment applies through the code’s status indicator.

A few other points shape what lands in the bank:

• Payment goes to the facility, either the HOPD or the ASC, never to the performing surgeon
• Pass-through status for device codes expires, so confirm the current status against the latest OPPS final rule
• Commercial payer contracts can treat the same device very differently from Medicare
• Any rate you carry over from last year needs re-checking before submission

Coverage depends on the note, not the code

Medicare covers C1814 when silicone oil is medically necessary as a tamponade agent during a covered vitreoretinal procedure. Coverage is never automatic. It rests on the primary surgical CPT code and on documentation that explains why oil was chosen over a gas alternative.

Coverage also varies by Medicare Administrative Contractor (MAC) jurisdiction. Each MAC publishes Local Coverage Determinations for retinal procedures, and some add documentation requirements or limits. Check the applicable LCD with your regional MAC before the claim goes out.

The same healthcare compliance documentation standards that govern patient records apply to the evidence behind a medical necessity claim.

Four coverage details are worth pinning to the desk:

• Medical necessity: the operative note must say why silicone oil was selected over another tamponade agent
• APC bundling: the device is often packaged into the payment for the primary procedure, so separate payment is not guaranteed
• Commercial payers: policies vary widely, and pre-authorization is common on non-Medicare claims
• MAC jurisdiction: always read your MAC’s LCD for retinal detachment repair and vitreoretinal surgery

How a C1814 claim moves from the OR to the payer

Four things decide whether the claim pays:

• When you report the code
• How many units you bill
• What the operative note captures
• Where the line sits on the claim form

The digital intake and procedure forms that capture operative detail should already match what the payer expects to see.

Report it only when the oil goes in

C1814 belongs on the claim when silicone oil is introduced into the vitreous cavity during a covered outpatient procedure. Do not report it when only gas tamponade is used, such as SF6 or C3F8. The device code follows the surgery and is never submitted on its own.

One unit per procedure, in most cases

C1814 is normally reported as a single unit. Payer policies differ when several syringes of oil are used in one session. Check your MAC policy and the payer contract before you bill more than one unit on a line.

What the operative note has to say

The note must record the procedure performed, silicone oil as the tamponade agent, laterality, and the clinical indication. Vague or missing documentation is the leading cause of C1814 denials on audit.

Capturing device usage at the point of care with medical forms for outpatient procedures stops the detail going missing later. Solid EHR and billing integration then keeps the note and the claim in step.

Where C1814 goes on the UB-04

HOPD claims use the UB-04. C1814 goes on its own line with the revenue code your chargemaster maps to surgical supplies or implants. ASC claims follow the same principle. The surgical CPT code and the device code share a claim, never a line item.

The modifiers that matter on a C1814 line

Modifiers on a device line tell the payer something the code alone cannot. Most reference pages list C1814 without any modifier guidance at all, which leaves coders guessing. The table below covers the ones that come up in HOPD and ASC billing.

RT and LT carry the most weight here. Medicare MACs and commercial payers alike expect a laterality modifier on any eye-specific procedure or device line. Leave one off and the claim returns as technically deficient, which costs a corrected submission and a fresh payment clock.

One thing no modifier can do is unpack a packaged device. If the status indicator packages C1814 into the APC for the surgical procedure, appending modifier 59 will not produce a second payment. It will, however, put the claim in front of an auditor.

The CPT codes that travel with C1814

Because C1814 is a device code, the surgery itself is always reported with a companion CPT code on the same claim. The pairings below reflect standard vitreoretinal practice. Which one applies depends on the procedure performed and on payer policy.

Treat these as common pairings rather than mandatory ones. Payers differ on device bundling, and many package C1814 into the APC payment for the companion CPT instead of paying it separately.

Don’t forget the removal claim

The oil eventually comes out, and that second surgery is a separate claim that trips up plenty of teams. Surgeons who remove it with a vitrectomy report 67036. Aspiration without a vitrector is usually reported with 67121. The two codes are bundled under Correct Coding Initiative edits, so never submit both.

Add modifier 58 when the removal falls inside the earlier procedure’s global period. C1814 is not reported again, because no device goes in. The American Academy of Ophthalmology walks through the removal scenarios in more detail.

Neighboring C-codes that look close but aren’t

Adjacent C-codes are a genuine hazard on a busy charge sheet, because the numbers sit one digit apart while the devices have nothing in common. Knowing the neighbors helps a coder catch a transposition before the claim leaves the building.

Proximity in the code range says nothing about clinical similarity. Pick C1814 only when the device used was silicone oil acting as a retinal tamponade. The AAPC HCPCS range index is a quick way to confirm an active descriptor before you bill.

Where C1814 claims go wrong

Denials on this code cluster around six mistakes, and every one of them is preventable at the desk. Each item below pairs the error with the fix.

• Wrong billing setting: the claim goes out from POS 11. Confirm the place of service is HOPD (POS 22) or ASC (POS 24) first.
• Missing laterality modifier: RT or LT is left off an eye-specific line. Make the modifier a standing rule on every C1814 line item.
• No companion CPT code: the device code arrives alone. Pair it with the surgical code, because C1814 never stands by itself.
• Incorrect units: multiple units go out without authorization. Default to one unit and check MAC policy before adding more.
• Thin operative documentation: the record never names silicone oil. Structured clinical record-keeping captures the device and the rationale at the point of care.
• Chasing a separate payment: a modifier is added to force reimbursement on a packaged device. Read the status indicator in Addendum B instead.

Before you submit: a 60-second check

Run this list before the claim leaves the facility:

• Place of service is 22 or 24
• RT or LT sits on the C1814 line
• A companion CPT code is on the claim
• Units read 1 unless the payer approved more
• The operative note names silicone oil and the indication
• The status indicator in Addendum B matches what you expect to be paid

How Pabau keeps device claim documentation in one place

None of those six errors starts in the billing office. Each one begins on the day of surgery, in a record that never captured what the coder needed. Laterality is absent from the note. The tamponade agent is unnamed. Consent sits in a scanned file nobody attached to the patient.

Practice management software like Pabau pulls that material into a single patient record. Digital forms capture consent and clinical history at intake. Treatment notes and photos attach to the same file, and billing and claims tools sit right beside them. When an auditor asks what happened in that eye on that date, the answer is in one place.

The size of the practice barely changes the habit. A single-site optometry and eye care team works from the same record structure as a multi-location US practice group. Documentation standards then travel with the patient, not the location.

Keep clinical detail and billing in one record

Pabau brings consent forms, treatment notes, and billing into a single patient record. The documentation behind every claim is captured at the point of care, not chased afterwards.

Book a demo

Conclusion

C1814 is a small code with a narrow window. Three things protect the claim: place of service, laterality, and an operative note that names the agent. Get those right and payment usually follows without a second look.

The judgment worth carrying forward is about packaging. Treat it as the default and build the claim to be clean rather than clever. Chasing a separate device payment with a modifier costs more in audit exposure than it will ever return.

Everything that protects this claim happens before anyone opens the billing screen. Pabau keeps consent, treatment notes, and billing in one patient record, so the detail a coder needs is already there. Book a demo to see how that works for an eye care practice.

Continue your research

Billing another eye device under OPPS? C1840 covers the telescopic intraocular lens, the other ophthalmic device code in this range.

Wondering why the code next to C1814 looks nothing like it? C1815 reports an implantable urinary sphincter prosthesis.

Coding neurostimulator components on a facility claim? C1816 covers the implantable receiver and transmitter.

Reporting a surgical implant that isn’t a prosthesis? C1765 handles adhesion barriers and shows how supply-style devices are billed.

Billing a stent together with its delivery system? C1874 sets out how the combined device is reported.

Frequently asked questions